Facebook
Instagram
Linkedin
Soundcloud
Twitter
Youtube
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Search
FDAReview.org
A PROJECT OF THE INDEPENDENT INSTITUTE
Home
Blog
Issues
History of the FDA
Approval
Drug Development
Safety
Theory of Harm
FDA Incentives
Where Is the Market Failure Argument?
Medical Devices
Reform Options
Voluntary Provisions
Managing Risky Products
Publications
Features
Glossary
Links
Quotations
References
About
Donate
Home
2019
Yearly Archives: 2019
Blog
As Insulin Prices Rise, Diabetics Turn to Black Markets
Raymond March
-
July 9, 2019
0
Blog
San Francisco’s Vaping Ban Is Doomed To Go Up in Smoke
Raymond March
-
July 3, 2019
0
Blog
Right-to-Try Legislation Helps Patient Battling Bone Cancer
Raymond March
-
June 24, 2019
0
Blog
FDA Approves $2 Million Drug. Blame the Price on Excessive Regulation.
Raymond March
-
May 30, 2019
0
Blog
FDA To Stop Regulating the Amount of Cherries in Frozen Cherry Pie
Raymond March
-
May 15, 2019
0
Blog
Political Rhetoric Against Right-to-Try Laws Continues, Undermining Support for Medical Treatments of Last Resort
Raymond March
-
May 7, 2019
0
Blog
FDA Approves Ketamine-Based Drug to Treat Difficult Cases of Depression
Raymond March
-
March 28, 2019
0
Blog
Generic Insulin Now Available After Nearly One Hundred Years of Regulatory Protection From Competition
Raymond March
-
March 25, 2019
0
Blog
FDA Wants More Sunscreen Regulations, but Would Consumers Get Burned?
Raymond March
-
March 14, 2019
0
Blog
FDA Panel Backs Ketamine-Based Treatment for Depression
Raymond March
-
March 1, 2019
0
1
2
3
Page 2 of 3
